New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2014
10:25 EDTCYTK, CYTKSummer Street's chief scientific officer holds analyst/industry conference call
Chief Scientific Officer Classen discusses Cytokinetics' (CYTK) Tirasemtiv for treatment of Amyotrophic Lateral Sclerosis (ALS) on an Analyst/Industry conference call to be held on April 9 at 11 am.
News For CYTK From The Last 14 Days
Check below for free stories on CYTK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CYTK

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use